JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Farr, W. C.
Right arrow Articles by Grupp, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Farr, W. C.
Right arrow Articles by Grupp, G.
Journal of Pharmacology And Experimental Therapeutics, Vol. 156, Issue 3, 528-537, 1967
Copyright © 1967 by American Society for Pharmacology and Experimental Therapeutics


SYMPATHETICALLY MEDIATED EFFECTS OF ANGIOTENSIN ON THE DOG HEART IN SITU

William C. Farr 1 and Gunter Grupp 1

1 Department of Medicine, Cardiac Research Laboratory and Department of Pharmacology, University of Cincinnati, College of Medicine, Cincinnati, Ohio

Angiotensin II increases blood pressure, heart rate and contractile force in the anesthetized dog. The mechanism by which it produces these effects was studied in the dog heart in situ. The positive inotropic and chronotropic responses were not abolished after acute bilateral adrenalectomy or ganglionic blockade, but were markedly reduced by beta adrenergic blockade, reserpine or acute decentralization of the heart either surgically in situ or in the form of a heart-lung preparation. The results suggest that the predominant cardiac effects of angiotensin are not caused by the release of catecholamines into the circulation from the adrenal medulla, stimulation of the central nervous system, direct stimulation of the heart's beta receptors or the local release of catecholamines from the nerve terminals. The evidence suggests that angiotensin, at low doses (1 µg/kg), causes its predominant cardiac effects by the stimulation of the ganglion cells of the cardiac sympathetic nerves even in the presence of ganglionic blockade.

Submitted on September 30, 1966
Accepted on January 16, 1967







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1967 by the American Society for Pharmacology and Experimental Therapeutics.